Biotech Fluidics announce the foundation of Ventri Labs AB (VentriLabs) – a new subsidiary set-up to leverage the disruptive benefits of its patented gravity liquid pump technology for handling of sensitive media.

Use of conventional mechanical pumps is known to negatively affect sensitive biological materials limiting their use in bioprocessing, clinical and tissue engineering applications. Meticulously engineered to ensure delicate handling of sensitive media VentriLabs´ gravity-based pump technology is proven to reduce destructive mechanical and shearing effects by up to 95% while pumping blood, as compared to commonly used peristaltic pumps.

This innovative technology is also highly controllable, eliminating pulsation effects inherent in peristaltic and membrane pumps. In filtration applications this equates to improved efficiency and yields that translate into a more cost-efficient process for the user.

Dr Robin Öz, CEO of VentriLabs commented “Having committed multi-year funding from our parent company and a strong intellectual property portfolio – we are inviting collaborative partners and investors to accelerate the process, and further development of our groundbreaking liquid pump technology in lab, process and clinical applications.”

For further information about gravity liquid pump technology please visit www.ventrilabs.com or contact the VentriLabs on +46 (0) 300 52 13 86 / robin.oz@ventrilabs.com

VentriLabs is a pioneering Biotech and MedTech company, focused on innovative solutions in flow control and fluid transfer. Based on the proprietary gravity mediated pump technology, the company develops and supplies systems for the gentle handling of delicate fluids. Offering liquid flow with high precision and sensitivity combined with great versatility, VentriLabs´ innovative pumping technology excels across a multitude of technologies, ranging from general laboratory use and bioprocessing to clinical systems utilizing extracorporeal blood circulation. The Company is based in Gothenburg, Sweden and is a subsidiary of Biotech Fluidics. More information – www.ventrilabs.com.

Biotech Fluidics is a leading supplier of fluidic system solutions, liquid transfer components, degassing systems, and innovative laboratory technology to instrument developers, manufacturers, and distributors all around the world. The company’s mission is to empower its customers by designing and assembling unique products, being a reliable partner, offering first-class service, in-depth knowledge, and offering advanced technical support for all the items it provides. More information – www.biotechfluidics.com